- Recent Funding
- Investors
- Pathway to Cures
Pathway to Cures portfolio
Pathway to Cures has 1 portfolio company on record at Recent Funding.
About this page
It is an impact investor based in New York, US, founded in 2021. Its most recent investment on record is Spark Biomedical's $15M Series A round in April 2025, alongside Wave Ventures. That company is in Health and bio.
About Pathway to Cures
What Pathway to Cures invests in
- Health and bio · 1 · 100%
How Pathway to Cures invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series A | 1 100% | $15M |
Pathway to Cures portfolio companies
SSpark Biomedical$15MSeries A · Apr 2025
| Company | Round with Pathway to Cures | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series A · $15M | $15M | Apr 30, 2025 Series A |
Most frequent co-investors
Similar investors
IIzou Partners2 companies · 2 deals in 12 mo
- TThe Ljungstrom Family Office2 companies · 2 deals in 12 mo
OO'Shaughnessy Ventures3 companies · 1 deal in 12 mo
SSide Stage Ventures3 companies
AAble Partners4 companies · 1 deal in 12 mo
BBdc Thrive venture5 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.
Share is of the 1 round on Recent Funding that name Pathway to Cures. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Pathway to Cures, which is a subset of its real portfolio. API: /api/v1/investors/pathway-to-cures (get a free API key). More: the most active VC firms and new venture capital funds.